Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: John William Anderson who wrote (1643)	9/4/2002 12:14:50 PM
From: John William Anderson	Read Replies (1) \| Respond to of 1870

Genta news: Genta today announced the initiation of a new, multicenter clinical trial with its lead drug, Genasense(TM), in children with cancer. askmerrill.ml.com,{CDF68C20-759B-4274-AC99-E3C2EF855A85},00.html

To: John William Anderson who wrote (1643)	9/11/2002 3:41:42 PM
From: John William Anderson	Respond to of 1870

Short Interest Declining Aug 15, 2002 From Nasdaq. Settlement Date Short Interest Avg Daily Share Volume Days to Cover Aug. 15, 2002 11,895,854 473,062 25.15 Jul. 15, 2002 11,922,612 652,031 18.29 Jun. 14, 2002 12,005,089 1,608,270 7.46 May 15, 2002 12,798,679 1,652,405 7.75 Apr. 15, 2002 12,964,845 1,646,833 7.87 Mar. 15, 2002 13,186,500 1,214,779 10.86 Feb. 15, 2002 11,150,144 952,989 11.70 Jan. 15, 2002 9,281,789 1,266,396 7.33 Dec. 14, 2001 7,905,667 1,282,663 6.16 Nov. 15, 2001 6,056,387 1,033,291 5.86 Oct. 15, 2001 4,915,349 595,950 8.25 Sep. 14, 2001 4,338,156 614,371 7.06